by Scott Wallask | Feb 13, 2024 | Blog
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
by G2 Intelligence Staff | Sep 20, 2022 | Webinars
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
by Glenn S. Demby | Jun 10, 2022 | Articles , News , Open Content
With threats and attacks increasing, Congress has tabled a bill that would impose extra penalties on those seeking to harm healthcare staff.
by Rachel Muenz | Jun 10, 2022 | Articles , News , Open Content
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
by Rachel Muenz | May 12, 2022 | Articles , News , Open Content
Guidance from the American College of Medical Genetics and Genomics shares the importance of a genetic evaluation for hearing loss.
by G2 Intelligence Staff | Apr 21, 2022 | Webinars , Webinars & Labcasts , webinars free
This free webinar addresses annual billing changes and critical developments currently facing laboratory medicine.
by Oscelle Boye, MBiomed | Jun 5, 2025 | Clinical Diagnostics Insider , Testing Trends-dtet
Unharmonized and unstandardized test results can affect patient care. Here are steps that clinical labs can take to resolve this problem
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Jason Barker, ND | Jun 4, 2025 | Clinical Diagnostics Insider , Elite , Emerging Tests-dtet
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by G2 Intelligence Staff | May 30, 2025 | CLIA-lca , CLIA-nir , CMS-lca , CMS-lir , CMS-nir , Essential , Lab Industry Advisor
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Ron Shinkman | May 29, 2025 | CDC-nir , CLIA-lca , CLIA-nir , CMS-lca , CMS-lir , CMS-nir , Essential , FDA-lca , FDA-lir , FDA-nir , Lab Industry Advisor
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Oscelle Boye, MBiomed | May 22, 2025 | Compliance-lca , Compliance-nir , Essential , Lab Industry Advisor
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Ron Shinkman | May 22, 2025 | Essential , FDA-lca , FDA-lir , FDA-nir , Industry Buzz-lir , Lab Industry Advisor
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by G2 Intelligence Staff | May 19, 2025 | Jobs-lir , Lab Industry Advisor , Premium
The role at this point is theoretical, but our editors asked AI for help in drafting what the position might entail
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Tara Cepull, MA | May 16, 2025 | Elite , Jobs-lir , Lab Industry Advisor
While still in the early stages, Clinical Lab 2.0’s pitch for this new position fits with the need to better use lab data
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Scott Wallask | May 15, 2025 | DOJ-lca , DOJ-nir , Enforcement-lca , Enforcement-lir , Essential , Lab Industry Advisor
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by G2 Intelligence Staff | May 6, 2025 | OLP-Regular , Webinars
June 11th, 1:00pm ET Significant cases decided in 2024 and 2025 are shaping the landscape of enforcement for clinical laboratories. Government regulators continue to focus on medical necessity and improper business relationships, but they have expanded their focus to...